| Revenue growth | Q2 +28% YoY to ₹752 Cr; H1 +21% |
|---|---|
| Margins | Q2 EBITDA margin 18% vs 23% YoY; raw material pressure |
| Demand visibility | India demand growth cited; not quantified |
| Management confidence | Positive H2FY27 outlook; no numeric guidance |
Growth
Q2 revenue +28% on volume (+6%) and realisations. H1 revenue +21%, H1 PAT +25% (ex-DTL base).
Outlook
Positive H2FY27 outlook, no numeric guidance. CPVC, ECH, solar commissioning Q3FY27. Epoxy Resin and MPP H2FY28.
Risks
Raw material cost inflation compressed Q2 EBITDA margin to 18%. Geopolitical tensions, volatile prices, and seasonal off-season weighed on H1.
Investor Presentation filed with BSE, NSE: EPIGRAL. Summary written with AI assistance from the document.
Epigral Ltd: key numbers
- Share price
- ₹874.50
- Market cap
- ₹3,773 Cr
- Revenue (annual)
- ₹2,527 Cr
- Net profit (annual)
- ₹332.0 Cr
- P/E (TTM)
- 13.9×Sector 34.1×
- Promoter holding
- 68.83%+0.00% QoQ
- FII holding
- 0.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Epigral Ltd
All →Epigral Results Update
Epigral reported Q2 FY27 PAT of ₹64 Cr, up 26% YoY, with revenue at ₹752 Cr. EBITDA margin was 18% despite elevated raw material costs.
Epigral Q2 FY27 Results: Net Profit ₹65.1 Cr, Up 27.1% YoY
Epigral Ltd reported revenue from operations of ₹746 Cr (+27.0% YoY) and net profit of ₹65.1 Cr (+27.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹65.1 Cr · +27.1% YoY
Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Epigral Legal & Regulatory
Epigral received a Rs.28.11 crore income tax demand for AY 2023-24, including interest. The company considers the demand unmaintainable and is filing an appeal.
- Value
- ₹28.11 Cr
Epigral Board Meeting Date
Epigral schedules a board meeting on November 2, 2026 to approve unaudited Q2 and half-year results ended September 30, 2026. The notice is issued for shareholder information.
Epigral Other Announcement
Epigral Limited submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, regarding security dematerialization for the quarter ended September 30, 2026.